We predicted that individuals with a more favorable BDNF genotype (i.e., val/val) and higher lifetime PA levels would be older at clinical diagnosis and would demonstrate fewer current PD motor symptoms, including balance and gait, after controlling for years since diagnosis. Here, BDNF is linked to Parkinson disease.